MeMed Key Immunoassay Platform

Israel

MeMed is a leader in host response technologies that decode the body's complex signals into simple insights to improve patient outcomes. Leveraging expertise in host-response profiling and machine-learning algorithms, MeMed has developed a portfolio of tests addressing complex clinical dilemmas. The company has created MeMed Key®, a point-of-need rapid measurement platform ensuring timely availability of novel tests during clinician decision-making workflows. MeMed BV®, run on the MeMed Key platform, accurately determines the likelihood of bacterial or viral infections to enable improved patient management. Based on computational integration of bacterial and viral-responsive immune proteins, MeMed Key delivers MeMed BV results in 15 minutes from serum. This test has been clinically validated on thousands of patients, is CE-marked, and FDA cleared.